Cargando…
Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center
PURPOSE: Chemotherapy is commonly used for treatment in children over three years old with high-risk medulloblastoma(MB). However, little is currently known about the therapeutic benefits and side effects of intrathecal methotrexate(MTX), warranting further research. METHODS: In this retrospective s...
Autores principales: | Zhang, Yu-Tong, Wang, Yu, Zhong, Xiao-dan, Chang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462507/ https://www.ncbi.nlm.nih.gov/pubmed/37474745 http://dx.doi.org/10.1007/s11060-023-04388-2 |
Ejemplares similares
-
Subacute quadriplegic myelopathy following intrathecal methotrexate
por: Maramattom, Boby Varkey, et al.
Publicado: (2016) -
LINC-11. Intrathecal methotrexate in a young child with medulloblastoma with extensive nodularity. An alternative to intra-ventricular route in Low and Middle Income Countries?
por: Leal-Cavazos, Carlos, et al.
Publicado: (2022) -
Alemtuzumab and intrathecal methotrexate failed in the therapy of Rasmussen encephalitis
por: Liba, Zuzana, et al.
Publicado: (2017) -
Radiation Myelopathy Caused by Palliative Radiotherapy and Intrathecal Methotrexate
por: Fukuda, Yukiko, et al.
Publicado: (2022) -
Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis
por: Kang, Xun, et al.
Publicado: (2022)